Octreotide
-
Octreotide
structure -
-
CAS No:
79517-01-4
-
Formula:
C49H66N10O10S2
-
Chemical Name:
Octreotide
-
Synonyms:
SANDOSTATIN;SMS-201-995;[r-(r*,r*)]-d-phenylalanyl-l-cysteinyl-l-phenylalanyl-d-tryptophyl-l-lysyl-l-threonyl-n-[2-hydroxy-1-(hydroxy-methyl)propyl]-cysteinamide cyclic(2->7)-disulfide;OCTREOTIDE;OCTREOTIDE (SMS 201-995), ACETATE;cyclic(2-7)-disulfide,(r-l-threonyl-n-(2-hydroxy-1-(hydroxymethyl)propyl);d-phenylalanyl-l-cysteinyl-l-phenylalanyl-d-tryptophyl-l-lysyl-l-cysteinamid;r*))-(racetate(salt)
-
Categories:
Active Pharmaceutical Ingredients > Hormones and the Endocrine System
-
CAS No:
Description
Octreotide acetate, a long-acting synthetic analog of native somatostatin, inhibits growth hormone, glucagon, and insulin more potently.
Characteristics
382.82000
0.77
Colourless to off-white lyophilised solid
1.4±0.1 g/cm3
153-156°C
1447.2±65.0 °C at 760 mmHg
829.1±34.3 °C
1.673
H2O: soluble
−20°C
Intravenous-rat LD50: 18.1 mg/kg; Intravenous-mouse LD50: 72.3 mg/kg
Combustible; Fire site decomposes toxic nitrogen oxides, sulfur oxide fumes
D20 -42° (c = 0.5 in 95% acetic acid)
12.6None
Safety Information
NONH for all modes of transport
3
Treasury is low temperature, ventilated, dry; stored separately from food raw materials
|Warning|H315 (75%): Causes skin irritation [Warning Skin corrosion/irritation]|P261, P264, P271, P280, P302+P352, P304+P312, P304+P340, P305+P351+P338, P312, P321, P332+P313, P337+P313, and P362|Aggregated GHS information provided by 4 companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Computed Properties
Molecular Weight:1139.3
Hydrogen Bond Donor Count:15
Hydrogen Bond Acceptor Count:18
Rotatable Bond Count:17
Exact Mass:1138.48273942
Monoisotopic Mass:1138.48273942
Topological Polar Surface Area:457
Heavy Atom Count:79
Complexity:1780
Defined Atom Stereocenter Count:2
Undefined Atom Stereocenter Count:8
Covalently-Bonded Unit Count:3
Compound Is Canonicalized:Yes
Drug Function and Efficacy
It can inhibit the pathological excessive secretion of growth hormone, thyroid-stimulating hormone, gastrointestinal and pancreatic endocrine hormones; it can selectively reduce the blood flow and pressure of the portal vein and its collateral circulation, and reduce the pressure of varicose veins in the esophagus and gastric fundus; it can inhibit gallbladder emptying and have a therapeutic effect on pancreatic lesions; it can inhibit the secretion of gastric acid and gastrin, and improve the blood supply to the gastric mucosa; it can inhibit gastrointestinal motility.
Registered Holders
-
HYBIO PHARMACEUTICAL CO., LTD.
Active
European Union
-
PolyPeptide Laboratories (Sweden) AB
Active
European Union
-
CHENGDU SHENGNUO BIOPHARM CO., LTD.
Active
European Union
Recommended Suppliers of Octreotide
-
CN
YRS
Business licensed Certified factoryManufactory Supplier of Cosmetics raw materials,Pesticide intermediate,Photoelectric material,pharmaceutical intermediates,Raw materials for food and health products,Polymer materials,Fine Chemicals,Synthetic customization -
CN
YRS
Business licensed Certified factoryManufactory Supplier of fine chemicals,pharmaceutical materialsInquiryUnit Price: nullnull /null nullCAS No.: 79517-01-4Grade: industrial GradeContent: 98% -
CN
YRS
Business licensedTrader Supplier of Semaglutide,Tirzepatide,Lixisenatide,Teduglutide,Retatrutide,Tirzepatide,Cagrilintide,Linaclotide,Octreotide Acetate,Sincalide,L- LYSINE MONOHYDRATE -
CN
YRS
Business licensedTrader Supplier of ghk cuInquiryUnit Price: nullnull /null nullCAS No.: 79517-01-4Grade: Pesticide GradeContent: 99% -
CN
YRS
Business licensedTrader Supplier of Peptide,API,HCG,Amino Acids,Plant Extract,VitaminInquiryUnit Price: nullnull /null nullCAS No.: 79517-01-4Grade: Pharmaceutical GradeContent: 99%
Learn More Other Chemicals
-
Octreotide acetate
83150-76-9
-
Ethyl (3S)-4-chloro-3-hydroxybutanoate
86728-85-0
-
Liraglutide
204656-20-2
-
Cabazitaxel Formula
183133-96-2
-
(7α)-3-Hydroxy-7-methylestra-1,3,5(10)-trien-17-one Formula
10448-96-1
-
Quingestanol Formula
10592-65-1
-
Vasopressin Structure
11000-17-2
-
Bovine Insulin Structure
11070-73-8
-
What is (+/-)-15-DEOXY-[16RS]-16-HYDROXY-16-METHYLPROSTAGLANDIN E1
112137-89-0
-
What is Spiro[isobenzofuran-1(3H),2′-[2H]pyran]-3′,4′,5′-triol, 6-[(4-ethylphenyl)methyl]-3′,4′,5′,6′-tetrahydro-6′-(hydroxymethyl)-, hydrate (1:1), (1S,3′R,4′S,5′S,6′R)-
1201913-82-7